WHO report calls for urgent action to protect malaria therapies.
The Global plan for artemisinin resistance containment (GPARC) is a call to action for all members of the Roll Back Malaria (RBM) Partnership. The document is a companion to the Global report on antimalarial drug efficacy and drug resistance: 2000–2010, which provides the extensive evidence on which the GPARC was based. The GPARC sets out a high-level plan of attack to protect ACTs as an effective treatment for Plasmodium falciparum malaria.
View this report on the WHO website.